لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Philip A. Gregory, Margaret M. Centenera, Lisa M. Butler, Brett G. Hollier, Rajdeep Das, Nataly Stylianou, Wayne D. Tilley, Scott L. Townley, Adrienne R. Hanson, Amina Zoubeidi, Gregory J. Goodall, Carolina Soekmadji, Katrina Sweeney, Colleen C. Nelson, Isabel Coutinho, Lidija Jovanovic, Luke A. Selth

المساهمون: Selth, LA, Das, R, Townley, SL, Coutinho, I, Hanson, AR, Centenera, MM, Stylianou, N, Sweeney, K, Soekmadji, C, Jovanovic, L, Nelson, CC, Zoubeidi, A, Butler, LM, Goodall, GJ, Hollier, BG, Gregory, PA, Tilley, WD

المصدر: Europe PubMed Central

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Epithelial-Mesenchymal Transition, Gene Expression, Biology, Molecular oncology, Epithelium, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Circulating tumor cell, Cell Line, Tumor, microRNA, Genetics, medicine, Animals, Humans, Epithelial–mesenchymal transition, Molecular Biology, Transcription factor, 3' Untranslated Regions, epithelial plasticity, Adaptor Proteins, Signal Transducing, YAP1, Prostatic Neoplasms, Zinc Finger E-box-Binding Homeobox 1, YAP-Signaling Proteins, Cell cycle, Proto-Oncogene Proteins c-met, medicine.disease, ZEB1-miR-375-YAP1, prostate cancer, Neoplastic Cells, Circulating, Phosphoproteins, Molecular biology, Gene Expression Regulation, Neoplastic, MicroRNAs, 030104 developmental biology, Phenotype, 030220 oncology & carcinogenesis, Cancer research, RNA Interference, Biomarkers, Signal Transduction, Transcription Factors

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5549098e1f1e0f76eea7aa0600bb3b3b
https://pubmed.ncbi.nlm.nih.gov/27270433

المؤلفون: Shrestha RK; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Nassar ZD; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Hanson AR; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Iggo R; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Institut Bergonié Unicancer, INSERM, Bordeaux, France., Townley SL; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia., Dehairs J; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium., Mah CY; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Helm M; South Australian Health and Medical Research Institute, Adelaide, Australia., Alizadeh-Ghodsi M; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Pickering M; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Ghesquière B; Metabolomics Core Facility Leuven, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Applied Mass Spectrometry, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Watt MJ; Department of Physiology, University of Melbourne, Melbourne, Australia., Quek LE; School of Mathematics and Statistics, Charles Perkins Centre, Faculty of Science, The University of Sydney, Camperdown, Australia., Hoy AJ; School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium., Butler LM; South Australian Health and Medical Research Institute, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia., Selth LA; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, Australia.; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, Australia.

المصدر: Cancer research [Cancer Res] 2024 Jul 15; Vol. 84 (14), pp. 2313-2332.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/genetics , Coenzyme A Ligases*/metabolism , Coenzyme A Ligases*/genetics , Ferroptosis* , Fatty Acids*/metabolism , Cell Proliferation*, Male ; Humans ; Animals ; Mice ; Cell Line, Tumor ; Receptors, Androgen/metabolism ; Lipid Metabolism ; Xenograft Model Antitumor Assays

المؤلفون: Wang Z; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA.; Yale Stem Cell Center, Department of Cell Biology and Department of Genetics, Yale University School of Medicine, New Haven, CT, 06510, USA., Townley SL; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, 5042, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, SA, 5042, Australia., Zhang S; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA., Liu M; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA., Li M; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA., Labaf M; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.; Department of Mathematics, University of Massachusetts Boston, Boston, MA, 02125, USA., Patalano S; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA., Venkataramani K; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA., Siegfried KR; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA., Macoska JA; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA., Han D; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA., Gao S; Department of Cell Biology and Anatomy, New York Medical College, Valhalla, New York, 10595, USA.; Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, New York, 10595, USA., Risbridger GP; Melbourne Urological Research Alliance, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, VIC, 3800, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, 3010, Australia.; Cabrini Institute, Cabrini Health, Malvern, VIC, 3144, Australia., Taylor RA; Melbourne Urological Research Alliance, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, 3010, Australia.; Cabrini Institute, Cabrini Health, Malvern, VIC, 3144, Australia.; Department of Physiology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, VIC, 3800, Australia., Lawrence MG; Melbourne Urological Research Alliance, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, VIC, 3800, Australia.; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, 3010, Australia.; Cabrini Institute, Cabrini Health, Malvern, VIC, 3144, Australia., He HH; Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G1L7, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, ON, M5G1L7, Canada., Selth LA; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, 5042, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, SA, 5042, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, 5000, Australia., Cai C; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA. changmeng.cai@umb.edu.; Department of Biology, University of Massachusetts Boston, Boston, MA, 02125, USA. changmeng.cai@umb.edu.

المصدر: Nature communications [Nat Commun] 2024 Jun 08; Vol. 15 (1), pp. 4914. Date of Electronic Publication: 2024 Jun 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Hepatocyte Nuclear Factor 3-beta*/metabolism , Hepatocyte Nuclear Factor 3-beta*/genetics , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/pathology , Transcription Factor AP-1*/metabolism , Transcription Factor AP-1*/genetics , Gene Expression Regulation, Neoplastic* , Cell Lineage*/genetics, Male ; Humans ; Cell Line, Tumor ; Histone Demethylases/metabolism ; Histone Demethylases/genetics ; Hepatocyte Nuclear Factor 3-alpha/metabolism ; Hepatocyte Nuclear Factor 3-alpha/genetics ; Receptors, Androgen/metabolism ; Receptors, Androgen/genetics ; Animals ; Chromatin/metabolism ; Chromatin/genetics ; Cell Plasticity/genetics ; Cellular Reprogramming/genetics ; Mice ; Proto-Oncogene Proteins c-jun/metabolism ; Proto-Oncogene Proteins c-jun/genetics ; Enhancer Elements, Genetic/genetics ; Transcription, Genetic

المؤلفون: Alizadeh-Ghodsi M; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.; Freemasons Centre for Male Health and Wellbeing, The University of Adelaide, Adelaide, SA, Australia., Owen KL; Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Townley SL; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, SA, Australia., Zanker D; Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Rollin SPG; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, SA, Australia., Hanson AR; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, SA, Australia., Shrestha R; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.; Freemasons Centre for Male Health and Wellbeing, The University of Adelaide, Adelaide, SA, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia., Toubia J; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; ACRF Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology and University of South Australia, Frome Road, Adelaide, SA, Australia., Gargett T; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia., Chernukhin I; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Luu J; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Cowley KJ; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Clark A; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia., Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Simpson KJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Winter JM; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia., Lawrence MG; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Cabrini Institute, Malvern, Victoria, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia., Butler LM; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Risbridger GP; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Cabrini Institute, Malvern, Victoria, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia., Thierry B; ARC Centre of Excellence in Convergent Bio and Nano Science and Technology, University of South Australia, Frome Road, Adelaide, SA, Australia.; Future Industries Institute, University of South Australia, Mawson Lakes, SA, Australia., Taylor RA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Cabrini Institute, Malvern, Victoria, Australia.; Melbourne Urological Research Alliance (MURAL), Monash Biomedicine Discovery Institute Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Physiology, Monash University, Clayton, Victoria, Australia., Hickey TE; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia., Parker BS; Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.; Freemasons Centre for Male Health and Wellbeing, The University of Adelaide, Adelaide, SA, Australia., Selth LA; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia.; Freemasons Centre for Male Health and Wellbeing, Flinders University, Bedford Park, SA, Australia.

المصدر: Cancer research communications [Cancer Res Commun] 2022 Jul 25; Vol. 2 (7), pp. 706-724. Date of Electronic Publication: 2022 Jul 25 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun

مواضيع طبية MeSH: Receptors, Androgen*/genetics , Prostatic Neoplasms*/drug therapy, Male ; Humans ; Animals ; Mice ; Androgens/pharmacology ; Androgen Antagonists/pharmacology ; CD8-Positive T-Lymphocytes/metabolism ; DNA